Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To demonstrate that zoledronic acid 5 mg i.v. given annually at randomization and Month 12 is superior to placebo in percent change of BMD at the lumbar spine at Month 24 relative to baseline in Stratum I (women < 5 years from menopause) and in Stratum II (women ≥ 5 years from menopause) - To demonstrate that zoledronic acid 5 mg i.v. given at randomization only is superior to placebo in percent change of BMD at the lumbar spine at Month 24 relative to baseline in Stratum I and in Stratum II
Critère d'inclusion
- Postmenopausal osteoporosis